Mobile

A Phase II, Multicentre, Double-blind, Placebo Controlled, Pilot Study to Evaluate the Safety and Efficacy of CUV1647 Administered as A Subcutaneous Bioresorbable 16mg Implant in Patients Undergoing P...

Update Il y a 4 ans
Reference: EUCTR2008-002446-39

A Phase II, Multicentre, Double-blind, Placebo Controlled, Pilot Study to Evaluate the Safety and Efficacy of CUV1647 Administered as A Subcutaneous Bioresorbable 16mg Implant in Patients Undergoing Photodynamic Therapy (PDT) utilising Porfimer Sodium

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To determine whether CUV1647 implants can reduce the period of phototoxicity experienced by patients who have undergone photodynamic therapy with porfimer sodium.

Inclusion criteria

  • Barrett's Oesohagus Cholangiocarcinoma

Links